The Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration Oct. 6 released a temporary rule extending telehealth prescribing flexibilities for buprenorphine and other controlled substances for new practitioner-patient relationships through Dec. 31, 2024.
The Senate Health, Education, Labor and Pensions Committee voted 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333), which would reauthorize the Hospital Preparedness Program at the current funding level of $385 million through fiscal year 2029.
The AHA, American Medical Association, American Society of Anesthesiologists, American Society of Health-System Pharmacists, and Association for Clinical Oncology are urging the Drug Enforcement Agency to allow drug manufacturers and 503B outsourcing facilities to receive increased annual…
Multidisciplinary teams at the University of Tennessee Medical Center used lean methodology to create evidence-based care plans throughout any episode of care, including the ED, outpatient, inpatient, post-acute and home care.
The Food and Drug Administration yesterday approved the first test to use next generation sequencing technology to detect HIV drug-resistance mutations in patients taking or about to start antiviral therapy.
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices today voiced strong support for the Mitigating Emergency Drug Shortages Act.
The Food and Drug Administration today alerted the public to growing concern about the potential for medical device shortages as facilities that sterilize devices using ethylene oxide close.
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.